Resources | NITAG RESOURCE CENTER

2023 ∙ ATAGI

ATAGI Update on the COVID-19 Vaccination Program

2023 ∙ ATAGI

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older

2023 ∙ ATAGI

ATAGI advice on seasonal influenza vaccines in 2023

2023 ∙ ATAGI

ATAGI 2023 booster advice

2023 ∙ ATAGI

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine

2022 ∙ Xu, B. Zhu, Y.

A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine

2022 ∙ Wang, D. Wu, J. Du, J. Ong, H. Tang, B. Dozier, M. Weller, D. Campbell, C.

Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature

2022 ∙ Bai, X. Chen, L. Liu, X. Tong, Y. Wang, L. Zhou, M. Li, Y. Hu, G.

Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review

2022 ∙ Ma, Y. Ren, J. Zheng, Y. Cai, D. Li, S. Li, Y.

Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis

2022 ∙ Chen, Z. Peng, Y. Wu, X. Pang, B. Yang, F. Zheng, W. Liu, C. Zhang, J.

Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis